All In Biotech

Drug Trial Radar · NCT00265850

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

A Phase III Trial of Irinotecan / 5-FU / Leucovorin or Oxaliplatin / 5-FU/ Leucovorin With Bevacizumab, or Cetuximab (C225), or With the Combination of Bevacizumab and Cetuximab for Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum

Last checked: Nov 19, 2026Latest source record: Aug 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,334 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,334

Actual

Start

Nov 2005

Primary completion

Feb 2015

Study completion Jan 2018

Sponsor

Lead sponsor
Alliance for Clinical Trials in OncologyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI); SWOG Cancer Research Network; Bristol-Myers Squibb; Aptuit
First posted
Dec 15, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

PURPOSE: This randomized phase III trial is studying cetuximab and/or bevacizumab when given together with combination chemotherapy to compare how well they work in treating patients with metastatic colorectal cancer. RATIONALE: Monoclonal antibodies, such as cetuximab and bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Cetuximab may also stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Drugs used in chemotherapy, such as fluorouracil, leucovorin, oxaliplatin, and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving monoclonal antibodies together with combination chemotherapy may kill more tumor cells. It is not yet known whether combination chemotherapy is more effective with cetuximab and/or bevacizumab in treating patients with colorectal cancer.

Conditions

  • Colorectal Cancer

Interventions

  • bevacizumabBiological

    Given IV

  • cetuximabBiological

    Given IV

  • FOLFOX orDrug

    Patients receive oxaliplatin 85 mg/m\^2 IV infused over two hours followed by leucovorin 400 mg/m\^2 IV over 2 hours followed by 5-FU 400 mg/m\^2 IV bolus, then 2400 mg/m\^2 continuous IV infusion over 46-48 hours

  • FOLFIRIDrug

    Patients receive irinotecan 180 mg/m\^2 IV infused over 90 minutes followed by leucovorin 400 mg/m\^2 IV over 2 hours followed by 5-FU 400 mg/m\^2 IV bolus following leucovorin then 2400 mg/m\^2 continuous IV infusion over 46-48 hours.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall SurvivalTime frame: Up to 5 years post-treatment

Locations

683 sites in 2 countries. Site status is shown where the registry gives one.

  • Providence Cancer Center at Providence Hospital

    Mobile, Alabama

  • Alaska Regional Hospital Cancer Center

    Anchorage, Alaska

  • Providence Cancer Center

    Anchorage, Alaska

  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center

    Fort Smith, Arkansas

  • NEA Medical Center - Stadium Boulevard

    Jonesboro, Arkansas

  • Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center

    Burbank, California

  • East Bay Radiation Oncology Center

    Castro Valley, California

  • Valley Medical Oncology Consultants - Castro Valley

    Castro Valley, California

  • North Bay Cancer Center

    Fairfield, California

  • Kaiser Permanente - Fremont

    Fremont, California

  • Valley Medical Oncology

    Fremont, California

  • Glendale Memorial Hospital Comprehensive Cancer Center

    Glendale, California

  • California Cancer Care, Incorporated - Greenbrae

    Greenbrae, California

  • Kaiser Permanente Medical Center - Hayward

    Hayward, California

  • Veterans Affairs Medical Center - Loma Linda (Pettis)

    Loma Linda, California

  • USC/Norris Comprehensive Cancer Center and Hospital

    Los Angeles, California

  • Contra Costa Regional Medical Center

    Martinez, California

  • Tibotec Therapeutics - Division of Ortho Biotech Products, LP

    Marysville, California

  • Camino Medical Group - Treatment Center

    Mountain View, California

  • El Camino Hospital Cancer Center

    Mountain View, California

  • Alta Bates Summit Medical Center - Summit Campus

    Oakland, California

  • Bay Area Breast Surgeons, Incorporated

    Oakland, California

  • CCOP - Bay Area Tumor Institute

    Oakland, California

  • Larry G Strieff MD Medical Corporation

    Oakland, California

  • Tom K Lee, Incorporated

    Oakland, California

  • Kaiser Permanente Medical Center - Oakland

    Oakland, California

  • St. Joseph Hospital Regional Cancer Center - Orange

    Orange, California

  • Desert Regional Medical Center Comprehensive Cancer Center

    Palm Springs, California

  • Palo Alto Medical Foundation

    Palo Alto, California

  • Valley Medical Oncology Consultants - Pleasanton

    Pleasanton, California

  • Kaiser Permanente Medical Center - Redwood City

    Redwood City, California

  • Kaiser Permanente Medical Center - Richmond

    Richmond, California

  • Kaiser Permanente Medical Center - Roseville

    Roseville, California

  • University of California Davis Cancer Center

    Sacramento, California

  • South Sacramento Kaiser-Permanente Medical Center

    Sacramento, California

  • Kaiser Permanente Medical Center - Sacramento

    Sacramento, California

  • Kaiser Permanente Medical Office -Vandever Medical Office

    San Diego, California

  • Naval Medical Center - San Diego

    San Diego, California

  • San Francisco General Hospital Medical Center

    San Francisco, California

  • Kaiser Permanente Medical Center - San Francisco Geary Campus

    San Francisco, California

Showing 40 of 683 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.